We are live on
!
Find out more
Nisa Investment Advisors Portfolio holdings
AUM
$32B
1-Year Est. Return
32.86%
This Fund
S&P 500
This Quarter
Est. Return
-13.98%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$11.4B
AUM Growth
-$2.76B
(-19%)
Cap. Flow
-$596M
Cap. Flow
% of AUM
-5.21%
Top 10 Holdings %
Top 10 Hldgs %
21.68%
Holding
2,580
New
224
Increased
846
Reduced
823
Closed
214
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones REIT ETF
RWR
|
+$25.6M |
| 2 |
Apple
AAPL
|
+$10.5M |
| 3 |
Microsoft
MSFT
|
+$7.64M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$6.83M |
| 5 |
Warner Bros
WBD
|
+$5.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$339M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$264M |
| 3 |
Vanguard Long-Term Corporate Bond ETF
VCLT
|
+$59.2M |
| 4 |
AT&T
T
|
+$19.9M |
| 5 |
Amazon
AMZN
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.82% |
| 2 | Healthcare | 14.55% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRDX
2076
DELISTED
Surmodics
SRDX
| $18K | ﹤0.01% |
+490
| New | +$19K |
|
2077
Viemed Healthcare
VMD
$355M
| $18K | ﹤0.01% |
3,400
+700
| +26% | +$3.77K |
|
|
ATSG
2078
DELISTED
Air Transport Services Group
ATSG
| $18K | ﹤0.01% |
640
| – | – |
|
2079
Arbutus Biopharma
ABUS
$907M
| $17K | ﹤0.01% |
6,150
+3,450
| +128% | +$8.83K |
|
2080
Cal-Maine
CALM
$3.85B
| $17K | ﹤0.01% |
340
-340
| -50% | -$17.3K |
|
2081
Liberty Latin America Class C
LILAK
$1.65B
| $17K | ﹤0.01% |
+2,398
| New | +$19.9K |
|
2082
Lightwave Logic
LWLG
$1.17B
| $17K | ﹤0.01% |
+2,580
| New | +$22.4K |
|
2083
Vaxcyte
PCVX
$8.67B
| $17K | ﹤0.01% |
791
-739
| -48% | -$17.1K |
|
2084
Perdoceo Education
PRDO
$1.97B
| $17K | ﹤0.01% |
+1,470
| New | +$16.1K |
|
2085
Protolabs
PRLB
$2.14B
| $17K | ﹤0.01% |
359
+9
| +3% | +$417 |
|
2086
Replimune Group
REPL
$1.15B
| $17K | ﹤0.01% |
+1,000
| New | +$16.4K |
|
2087
Shell
SHEL
$249B
| $17K | ﹤0.01% |
327
-10
| -3% | -$562 |
|
2088
TC Energy
TRP
$66B
| $17K | ﹤0.01% |
331
+66
| +25% | +$3.68K |
|
2089
Ubiquiti
UI
$34.5B
| $17K | ﹤0.01% |
70
+30
| +75% | +$7.98K |
|
|
VERV
2090
DELISTED
Verve Therapeutics
VERV
| $17K | ﹤0.01% |
+1,100
| New | +$17K |
|
|
LGTY
2091
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $17K | ﹤0.01% |
1,040
+670
| +181% | +$11.6K |
|
|
NGMS
2092
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $17K | ﹤0.01% |
+1,300
| New | +$17.7K |
|
2093
Ameresco
AMRC
$1.34B
| $16K | ﹤0.01% |
362
| – | – |
|
|
CPRX
2094
DELISTED
Catalyst Pharmaceutical
CPRX
| $16K | ﹤0.01% |
+2,320
| New | +$17K |
|
2095
indie Semiconductor
INDI
$786M
| $16K | ﹤0.01% |
+2,740
| New | +$18.9K |
|
2096
Innoviva
INVA
$1.49B
| $16K | ﹤0.01% |
+1,110
| New | +$18.2K |
|
|
KRON
2097
DELISTED
Kronos Bio
KRON
| $16K | ﹤0.01% |
4,300
+1,900
| +79% | +$8.61K |
|
2098
Protagonist Therapeutics
PTGX
$9.71B
| $16K | ﹤0.01% |
2,000
-24,390
| -92% | -$295K |
|
2099
Sunrun
RUN
$2.38B
| $16K | ﹤0.01% |
700
-50,000
| -99% | -$1.2M |
|
|
NEUE
2100
DELISTED
NeueHealth
NEUE
| $16K | ﹤0.01% |
+113
| New | +$16.4K |
|
Similar funds
GAM
Nisa Investment Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Nisa Investment Advisors held 2,580 positions worth $11.4B, down 19% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nisa Investment Advisors withdrew a net $596M in Q2 2022, closing 214 positions and reducing 823 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $339M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nisa Investment Advisors opened a new position in State Street SPDR Dow Jones REIT ETF worth $23M.
- Nisa Investment Advisors's largest Q2 2022 buy was State Street SPDR Dow Jones REIT ETF: 241,929 shares worth $23M.
- Nisa Investment Advisors added most to Apple in Q2 2022, an estimated $10.5M increase.
- Nisa Investment Advisors's biggest Q2 2022 reduction was Vanguard S&P 500 ETF, cutting an estimated $264M.
- Nisa Investment Advisors fully exited iShares Core S&P 500 ETF in Q2 2022, selling an estimated $339M.
- Nisa Investment Advisors's ten largest holdings make up 22% of its $11.4B portfolio in Q2 2022.
- Nisa Investment Advisors opened 224 new positions and closed 214 in Q2 2022.
- Nisa Investment Advisors's portfolio value fell 19% quarter-over-quarter to $11.4B.
Based on Nisa Investment Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.